This promotional symposium is organised and fully funded by Bayer Plc. It is intended for UK Healthcare professionals only. Bayer products will be discussed at this symposium. Adverse event reporting and prescribing information is available at this session.

This interactive symposium will aim to highlight the importance of early identification and subsequent optimisation of people with chronic kidney disease associated with type 2 diabetes.   The session aims to provide you with practical tips on how you can ensure your patients are treated in line with guideline directed therapy in this rapidly evolving field.

RP-KER-GB-0959 Date of Prep August 2024